Qbrexza

Product NDC: 69489-411
11-digit product format: 694890411
Labeler code: 69489
Product ID: 69489-411_52537ea0-9410-1691-e063-6394a90a9468
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: glycopyrronium
Dosage form: CLOTH
Route: TOPICAL
Labeler: Journey Medical Corporation
Application: NDA210361
Marketing category: NDA
Marketing start: 2018-06-28
Substance: GLYCOPYRRONIUM TOSYLATE
Active strength: 2.4 g/100g
Pharmacologic classes: Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N210361-001	QBREXZA	GLYCOPYRRONIUM TOSYLATE	EQ 2.4% BASE	CLOTH / TOPICAL		RLD, RS	2018-06-28

Orange Book patents#

Current patent rows page 1 of 1 · 8 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N210361-001	10052267	2028-10-17	U-2398	Drug product	2018-09-20
N210361-001	8618160	2029-12-10	U-2398	Drug product	2018-09-20
N210361-001	9744105	2030-07-18	U-2398	Drug product	2018-09-20
N210361-001	10004717	2033-02-28	U-2398	Drug product	2018-09-20
N210361-001	10543192	2033-02-28		Drug product	2020-02-27
N210361-001	10548875	2033-02-28	U-2398	Drug substance, Drug product	2020-03-03
N210361-001	8859610	2033-02-28	U-2398	Drug product	2018-09-20
N210361-001	9259414	2033-02-28	U-2398		2018-09-20

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N210361-001	QBREXZA	EQ 2.4% BASE	CLOTH / TOPICAL	RLD, RS	2018-06-28	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210361-001	QBREXZA	EQ 2.4% BASE	CLOTH / TOPICAL	RLD, RS	2018-06-28	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N210361-001	QBREXZA	EQ 2.4% BASE	CLOTH / TOPICAL	RLD, RS	2018-06-28	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N210361-001	QBREXZA	EQ 2.4% BASE	CLOTH / TOPICAL	RLD, RS	2018-06-28	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N210361-001	QBREXZA	EQ 2.4% BASE	CLOTH / TOPICAL	RLD, RS	2018-06-28	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N210361-001	QBREXZA	EQ 2.4% BASE	CLOTH / TOPICAL	RLD, RS	2018-06-28	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N210361-001	QBREXZA	EQ 2.4% BASE	CLOTH / TOPICAL	RLD, RS	2018-06-28	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N210361-001	QBREXZA	EQ 2.4% BASE	CLOTH / TOPICAL	RLD, RS	2018-06-28	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N210361-001	QBREXZA	EQ 2.4% BASE	CLOTH / TOPICAL	RLD, RS	2018-06-28	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N210361-001	QBREXZA	EQ 2.4% BASE	CLOTH / TOPICAL	RLD, RS	2018-06-28	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N210361-001	QBREXZA	EQ 2.4% BASE	CLOTH / TOPICAL	RLD, RS	2018-06-28	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N210361-001	QBREXZA	EQ 2.4% BASE	CLOTH / TOPICAL	RLD, RS	2018-06-28	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N210361-001	QBREXZA	EQ 2.4% BASE	CLOTH / TOPICAL	RLD, RS	2018-06-28	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N210361-001	QBREXZA	EQ 2.4% BASE	CLOTH / TOPICAL	RLD, RS	2018-06-28	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N210361-001	QBREXZA	EQ 2.4% BASE	CLOTH / TOPICAL	RLD, RS	2018-06-28	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N210361-001	QBREXZA	EQ 2.4% BASE	CLOTH / TOPICAL	RLD, RS	2018-06-28	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N210361-001	QBREXZA	EQ 2.4% BASE	CLOTH / TOPICAL	RLD, RS	2018-06-28	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N210361-001	QBREXZA	EQ 2.4% BASE	CLOTH / TOPICAL	RLD, RS	2018-06-28	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N210361-001	QBREXZA	EQ 2.4% BASE	CLOTH / TOPICAL	RLD, RS	2018-06-28	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N210361-001	QBREXZA	EQ 2.4% BASE	CLOTH / TOPICAL	RLD, RS	2018-06-28	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N210361-001	QBREXZA	EQ 2.4% BASE	CLOTH / TOPICAL	RLD, RS	2018-06-28	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N210361-001	QBREXZA	EQ 2.4% BASE	CLOTH / TOPICAL	RLD, RS	2018-06-28	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N210361-001	QBREXZA	EQ 2.4% BASE	CLOTH / TOPICAL	RLD, RS	2018-06-28	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N210361-001	QBREXZA	EQ 2.4% BASE	CLOTH / TOPICAL	RLD, RS	2018-06-28	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N210361-001	QBREXZA	EQ 2.4% BASE	CLOTH / TOPICAL	RLD, RS	2018-06-28	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N210361-001	QBREXZA	EQ 2.4% BASE	CLOTH / TOPICAL	RLD, RS	2018-06-28	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N210361-001	QBREXZA	EQ 2.4% BASE	CLOTH / TOPICAL	RLD, RS	2018-06-28	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N210361-001	QBREXZA	EQ 2.4% BASE	CLOTH / TOPICAL	RLD, RS	2018-06-28	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N210361-001	QBREXZA	EQ 2.4% BASE	CLOTH / TOPICAL	RLD, RS	2018-06-28	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N210361-001	QBREXZA	EQ 2.4% BASE	CLOTH / TOPICAL	RLD, RS	2018-06-28	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N210361-001	QBREXZA	EQ 2.4% BASE	CLOTH / TOPICAL	RLD, RS	2018-06-28	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N210361-001	QBREXZA	EQ 2.4% BASE	CLOTH / TOPICAL	RLD, RS	2018-06-28	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N210361-001	QBREXZA	EQ 2.4% BASE	CLOTH / TOPICAL	RLD, RS	2018-06-28	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N210361-001	QBREXZA	EQ 2.4% BASE	CLOTH / TOPICAL	RLD, RS	2018-06-28	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N210361-001	QBREXZA	EQ 2.4% BASE	CLOTH / TOPICAL	RLD, RS	2018-06-28	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N210361-001	QBREXZA	EQ 2.4% BASE	CLOTH / TOPICAL	RLD, RS	2018-06-28	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N210361-001	QBREXZA	EQ 2.4% BASE	CLOTH / TOPICAL	RLD, RS	2018-06-28	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N210361-001	QBREXZA	EQ 2.4% BASE	CLOTH / TOPICAL	RLD, RS	2018-06-28	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N210361-001	QBREXZA	EQ 2.4% BASE	CLOTH / TOPICAL	RLD, RS	2018-06-28	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N210361-001	QBREXZA	EQ 2.4% BASE	CLOTH / TOPICAL	RLD, RS	2018-06-28	`cb3db0bc1861…`

Observed Orange Book patent history#

Patent history page 1 of 9 · 326 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N210361-001	10052267	2028-10-17	U-2398	Drug product	2018-09-20	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210361-001	8618160	2029-12-10	U-2398	Drug product	2018-09-20	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210361-001	9744105	2030-07-18	U-2398	Drug product	2018-09-20	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210361-001	10004717	2033-02-28	U-2398	Drug product	2018-09-20	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210361-001	10543192	2033-02-28		Drug product	2020-02-27	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210361-001	10548875	2033-02-28	U-2398	Drug substance, Drug product	2020-03-03	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210361-001	8859610	2033-02-28	U-2398	Drug product	2018-09-20	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210361-001	9259414	2033-02-28	U-2398		2018-09-20	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210361-001	10052267	2028-10-17	U-2398	Drug product	2018-09-20	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210361-001	8618160	2029-12-10	U-2398	Drug product	2018-09-20	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210361-001	9744105	2030-07-18	U-2398	Drug product	2018-09-20	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210361-001	10004717	2033-02-28	U-2398	Drug product	2018-09-20	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210361-001	10543192	2033-02-28		Drug product	2020-02-27	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210361-001	10548875	2033-02-28	U-2398	Drug substance, Drug product	2020-03-03	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210361-001	8859610	2033-02-28	U-2398	Drug product	2018-09-20	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210361-001	9259414	2033-02-28	U-2398		2018-09-20	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N210361-001	10052267	2028-10-17	U-2398	Drug product	2018-09-20	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N210361-001	8618160	2029-12-10	U-2398	Drug product	2018-09-20	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N210361-001	9744105	2030-07-18	U-2398	Drug product	2018-09-20	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N210361-001	10004717	2033-02-28	U-2398	Drug product	2018-09-20	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N210361-001	10543192	2033-02-28		Drug product	2020-02-27	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N210361-001	10548875	2033-02-28	U-2398	Drug substance, Drug product	2020-03-03	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N210361-001	8859610	2033-02-28	U-2398	Drug product	2018-09-20	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N210361-001	9259414	2033-02-28	U-2398		2018-09-20	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N210361-001	10052267	2028-10-17	U-2398	Drug product	2018-09-20	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N210361-001	8618160	2029-12-10	U-2398	Drug product	2018-09-20	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N210361-001	9744105	2030-07-18	U-2398	Drug product	2018-09-20	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N210361-001	10004717	2033-02-28	U-2398	Drug product	2018-09-20	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N210361-001	10543192	2033-02-28		Drug product	2020-02-27	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N210361-001	10548875	2033-02-28	U-2398	Drug substance, Drug product	2020-03-03	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N210361-001	8859610	2033-02-28	U-2398	Drug product	2018-09-20	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N210361-001	9259414	2033-02-28	U-2398		2018-09-20	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N210361-001	10052267	2028-10-17	U-2398	Drug product	2018-09-20	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N210361-001	8618160	2029-12-10	U-2398	Drug product	2018-09-20	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N210361-001	9744105	2030-07-18	U-2398	Drug product	2018-09-20	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N210361-001	10004717	2033-02-28	U-2398	Drug product	2018-09-20	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N210361-001	10543192	2033-02-28		Drug product	2020-02-27	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N210361-001	10548875	2033-02-28	U-2398	Drug substance, Drug product	2020-03-03	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N210361-001	8859610	2033-02-28	U-2398	Drug product	2018-09-20	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N210361-001	9259414	2033-02-28	U-2398		2018-09-20	`b8a1b40f171c…`

Observed Orange Book exclusivity history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Exclusivity code	Expiration	Source SHA-256
2021-12-28 21:50 UTC	2021-12	N210361-001	NP	2021-06-28	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N210361-001	NP	2021-06-28	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N210361-001	NP	2021-06-28	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N210361-001	NP	2021-06-28	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N210361-001	NP	2021-06-28	`c0c555d07b60…`

Additional Listing Data#

Finished product: Yes
Brand name base: Qbrexza
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
GLYCOPYRRONIUM TOSYLATE	2.4 g/100g

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
1PVF6JLU7B	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
2054118	Internal RxNorm lookup
2054120	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
5b372650-e56e-47a5-93e2-c0c292017059	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
138c3de2-4b03-4255-92b5-f022482d81bc	Product name	4	20260113
4dc252b1-bb5f-8bb6-4fa8-f3a45efd810e	Product name	5	20250304
f58f10d3-5fa9-4c2e-9a6e-77029e9ed80b	Product name	1	20231002
76dcac30-469f-4f92-9c55-70950d209446	Product name	1	20230809
132196a6-5117-4b6e-a9dd-27f2793580c6	Product name	1	20230112
ac1f888b-a1db-4d2e-abbc-973f21c2ce1b	Product name	1	20220720
d84dd569-7bf0-1410-25eb-017ef37dd406	Product name	9	20210902
7d8c8d5a-f174-4e6b-97b1-6fd615c5df9a	Product name	1	20210204
58b12de9-b891-41c7-9be6-ff47de5ec28b	Product name	1	20180828
9aff7b10-8e47-4b10-9a92-803440a37ce2	Product name	1	20180206
ce066c73-ca6f-49fc-83d4-d3cf6728e8a1	Product name	1	20160616
fb29b8a9-c2d0-42bb-aea8-9bc2a87db75a	Product name	1	20151113
ab7ba50c-5a47-47e6-8dd6-fa32a52559f6	Product name	1	20151109
29ae08d1-069f-9822-4820-152d5dc67797	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
69489-411-01	Qbrexza	2.8 g in 1 POUCH	CLOTH	2.8	5
69489-411-05	Qbrexza	5 in 1 CARTON	CLOTH	5	5
69489-411-30	Qbrexza	30 in 1 CARTON	CLOTH	30	5
69489-411-51	Qbrexza	2.8 g in 1 POUCH	CLOTH	2.8	5

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
69489-411-01	EA - Each	69489-411	8713448d-76d9-4960-878a-4f3fb6e44592	1	2021-12-08
69489-411-30	EA - Each	69489-411	fcaa28fe-bf49-4df9-b566-b824a6c6c109	1	2021-12-08

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
69489-411	QBREXZA (GLYCOPYRRONIUM) CLOTH [JOURNEY MEDICAL CORPORATION]	4	Current NDC, Legacy NDC, 4 package rows	20231220_5b372650-e56e-47a5-93e2-c0c292017059.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Qbrexza	GLYCOPYRRONIUM	Journey Medical Corporation	5b372650-e56e-47a5-93e2-c0c292017059	2026-05-21	Warnings, Adverse reactions	Exact identifier application applno (NDA): 210361 application number: NDA210361 ndc (product): 69489-411

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
1PVF6JLU7B	GLYCOPYRRONIUM TOSYLATE	1624259-25-1	GLYCOPYRRONIUM TOSYLATE
A14FB57V1D	GLYCOPYRRONIUM	740028-90-4	glycopyrronium

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
2054118	glycopyrronium 2.4 % Medicated Cloth	PSN	5b372650-e56e-47a5-93e2-c0c292017059	5
2054120	Qbrexza 2.4 % Medicated Cloth	PSN	5b372650-e56e-47a5-93e2-c0c292017059	5
2054120	glycopyrronium 24 MG/ML Medicated Pad [Qbrexza]	SBD	5b372650-e56e-47a5-93e2-c0c292017059	5
2054118	glycopyrronium 24 MG/ML Medicated Pad	SCD	5b372650-e56e-47a5-93e2-c0c292017059	5
2054118	glycopyrronium 2.4 % Medicated Cloth	SY	5b372650-e56e-47a5-93e2-c0c292017059	5
2054120	Qbrexza 2.4 % Medicated Cloth	SY	5b372650-e56e-47a5-93e2-c0c292017059	5
2054120	Qbrexza 24 MG/ML Medicated Pad	SY	5b372650-e56e-47a5-93e2-c0c292017059	5

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
69489-411-01	69489041101	2.8 g in 1 POUCH	2.8 g					Historical
69489-411-05	69489041105	5 POUCH in 1 CARTON (69489-411-05) / 2.8 g in 1 POUCH (69489-411-51)	5 pouch	2021-12-03	0000-00-00	Yes	No	Current
69489-411-30	69489041130	30 POUCH in 1 CARTON (69489-411-30) / 2.8 g in 1 POUCH (69489-411-01)	30 pouch	2021-12-03	0000-00-00	No	No	Current
69489-411-50	69489041150	5 POUCH in 1 CARTON (69489-411-50) > 2.8 g in 1 POUCH (69489-411-51)	5 pouch	2021-12-03	0000-00-00	Yes	No	Current
69489-411-51	69489041151	2.8 g in 1 POUCH	2.8 g					Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Qbrexza - Journey Medical Corporation \| Aphena Pharma Solutions - Maryland, LLC	Journey Medical Corporation \| Aphena Pharma Solutions - Maryland, LLC	2026-05-21	HUMAN PRESCRIPTION DRUG LABEL	5